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NeurodegenerationThe branched-chain amino acids (BCAAs) valine, leucine and isoleucine are essential amino acids involved in
several important brain functions. Although commonly used as nutritional supplements, excessive intake of
BCAAs might favour the establishment of neurotoxic conditions as indicated by the severe neurological
symptoms characterising inherited disorders of BCAA catabolism such as maple syrup urine disease
(MSUD). Recent evidence indicates that BCAAs induce excitotoxicity through mechanisms that require the
presence of astrocytes. In the present study, we evaluated the effects of BCAAs on microglia, the main im-
mune cells of the brain. As an experimental model we used primary microglial cells harvested from mixed
glial cultures that had been kept in normal or high BCAA medium (H-BCAA). We show that H-BCAA
microglial cells exhibit a peculiar phenotype characterized by a partial skewing toward the M2 state, with en-
hanced IL-10 expression and phagocytic activity but also increased free radical generation and decreased
neuroprotective functions. We suggest that such an intermediate M1/M2 phenotype might result in a less ef-
ﬁcient microglial response, which would promote the establishment of a low grade chronic inﬂammation and
increase the likelihood of neurodegeneration. Although based on in vitro evidence, our study adds on to an
increasing literature indicating that the increasing use of dietary integrators might deserve consideration
for the possible drawbacks. In addition to excitotoxicity, the altered immune proﬁle of microglia might rep-
resent a further mechanism by which BCAAs might turn into toxicants and facilitate neurodegeneration.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Valine, leucine and isoleucine are essential amino acids that share
side chain structure features to which the collective term branched-
chain amino acids (BCAAs) refers to. Unlike most of amino acids, only
a minor fraction of the dietary BCAAs is metabolized by the liver; the
largest part of BCAAs enters the systemic circulation to reach the main
sites of BCAA metabolism, namely skeletal muscles, adipose tissue and
brain [1,2].P, adenosine 5 -diphosphate;
; BME, basal Eagle's medium;
inducible nitric oxide synthase;
chondrial membrane potential;
ease; mTOR, mammalian target
saline; PFA, paraformaldehyde;
NF-α, tumor necrosis factor-α;
gy and Neurosciences, Istituto
Rome, Italy. Tel.: +39 06
l rights reserved.It has been estimated that in healthy subjects about 10% of infused
BCAAs reach the brain where they participate to several important
biochemical processes such as protein synthesis, energy production
and glutamate synthesis [1–3].
Although commonly used as nutritional supplements to improve
mental and physical performance [4,5], excessive intake of BCAAs
might favour the establishment of neurotoxic conditions and exert
negative consequences on brain functions. Neurotoxic effects of
BCAAs or their catabolic products are supported by the severe neuro-
logical symptoms characterising inherited disorders of BCAA catabo-
lism such as maple syrup urine disease (MSUD), in which levels of
BCAAs, as well as their branched-chain keto-acids, increases up to
about 30 folds in blood, urine and cerebrospinal ﬂuid, as compared
to control subjects, [6–8]. The negative impact of high BCAA levels
on neurons is further supported by recent experimental evidence in-
dicating that BCAAs are neurotoxic per se and enhance excitotoxicity
in cortical neuronal cultures through mechanisms that require the
presence of astrocytes and involve NMDA receptor activation [9].
In addition, hyperexcitability of cortical neurons by BCAAs, which
could facilitate excitotoxic events, has been demonstrated by electro-
physiological recordings in both cultured neurons and in motor cor-
tex slices from mice fed with BCAA-enriched diet [10].
651R. De Simone et al. / Biochimica et Biophysica Acta 1832 (2013) 650–659Besides neurons and astrocytes, high BCAA levels could inﬂuence
the functional activities of other types of brain cells, includingmicroglia,
the main macrophage population of brain parenchyma. Microglial cells
actively survey the brain parenchyma [11] to readily respond to signals
released fromdamaged cells or pathogens. This physiological protective
function, if not properly regulated, can turn into an aberrant microglial
activation and contribute to neurotoxicity. As described for peripheral
macrophages, the functions acquired by microglia during the process
of activation can either promote or attenuate the inﬂammatory re-
sponse, and though not yet fully deﬁned, the repertoire of microglial
phenotypes is likely to encompass the full spectrum ranging from the
exempliﬁed classically activated (pro- inﬂammatory, M1), to the alter-
natively activated (anti-inﬂammatory, M2) phenotypes [12]. The cor-
rect balance between pro- and anti-inﬂammatory activities is critical
for preserving tissue homeostasis and several local cues can disrupt it,
thus promoting neuronal impairment. BCAAs have been described to
inﬂuence immune functions and in particular to be required for lym-
phocyte responsiveness and supporting of other immune cell functions
[13] but, to the best of our knowledge, no studies have been devoted to
brain immune response.
In the present study,we evaluated the effects of BCAAs onmicroglial
reactivity through the analysis of several genes and markers associated
with either M1 or M2 phenotypes. As an experimental model we used
primary microglial cells harvested from mixed glial cultures that had
been cultivated in normal or high BCAA medium (H-BCAA) for several
days. We also compared speciﬁc functional properties of normal and
H-BCAA microglial cultures, including migration, phagocytosis and re-
action to a typical pro-inﬂammatory challenge such as bacterial endo-
toxin (lipopolysaccharide, LPS). We show that H-BCAAs inﬂuence
microglial gene expression proﬁle and immune properties, leading to
an intermediate phenotype characterized by a partial skewing toward
the M2 state, increased free radical generation and phagocytic activity,
and altered responsiveness to LPS.2. Materials and methods
2.1. Reagents
All cell culture reagents were from Invitrogen (Grand Island, NY,
U.S.A) and virtually endotoxin free (less then 10E.U./ml as deter-
mined by the manufacturer). LPS (from Escherichia Coli, serotype
026:B6), ADP, UDP and BCAAs were obtained from Sigma (Saint
Louis, MO, USA).Table 1
Primers used for real time PCR analyses.
Gene Primers sequence Acc. number
HPRT Forward 5 -CTC ATG GAC TGA TTA TGG ACA GGA C-3 S79292
Reverse 5 -GCA GGT CAG CAA AGA ACT TAT AGC C-3
Product size:123 bp
IL-1β Forward 5 - CAC CTC TCA AGC AGA GCA CAG-3 M98820
Reverse 5 -GGG TTC CAT GGT GAA GTC AAC-3
Product size 79 bp
iNOS Forward 5 -GCC ACC TCG GAT ATC TCT TG-3 NM_0126113
Reverse 5 -TCT GGG TCC TCT GGT CAA AC-3
Product size 81 bp
TNF-α Forward 5 -AAAGGGCTCCCTCTCATCAGT-3 NM_012675.3
Reverse 5 -TCTGCTTGGTGGTTTGCTACGA-3
Product size 109 bp
IL-10 Forward 5 -GCCAAGCCTTGTCAGAAATGA-3 NM_012854.2
Reverse 5 -TTTCTGGGGCCATGGTTCTCT-3
Product size 73 bp
Arg-1 Forward 5 -ATATCTGCCAAGGACATCGTG-3 N0_17134
Reverse 5 -AGGTCTCTTCCATCACTTTGC-3
Probe: 5 -CAATGACTGAAGTGGACAAGCTGGGA-3
Product size 141 bp
MRC-1 Forward 5 -TGG ACT AAG CCA AGG GGC AA-3 NM_001106123
Reverse 5 -CAG GAG CAG GGG GAG TCT CA-3
Product size 121 bp2.2. Cell cultures
Mixed primary glial cultures were obtained from the cerebral cortex
of 1-day-old rats, as previously described [14] and in accordance with
the European Communities Council Directive N. 86/609/EEC.Mixed pri-
mary glial cultures were maintained for 4 days in Basal Eagle's Medium
(BME), supplemented with 10% heat-inactivated fetal bovine serum,
2 mM glutamine and 100 μg/ml gentamicin (control medium). Culture
medium was then replaced by fresh control medium or high BCAA
medium (H-BCAA), consisting in control medium supplemented with
10 mM valine, leucine and isoleucine (1:1:1) or additioned with
1 mM BCAAs when indicated. After 6 days, microglial cells were
harvested by mild shaking and resuspended in control medium or
H-BCAA and plated on uncoated plastic wells at a density of
1.5×105 cells/cm2. Cells were allowed to adhere for 20 min and then
washed to remove non-adhering cells. The cultures were maintained
in control medium or H-BCAA for 24 h before further analysis and
throughout the entire experimental period. Cell viability was greater
than 95% in both culture conditions, as tested by Trypan Blue exclusion
or MTT assay (see below).2.3. Actin staining and immunocytochemistry
Puriﬁed microglia were plated on coverslips at a density of 1.5×
105 cell/cm2 and cultured for 24 h in controlmediumor 10 mM H-BCAA.
Cells were then ﬁxed with 4% PFA and pre-incubated in T-PBS (0.025%
Triton in PBS) plus 5% BSA for 30 min, followed by incubation with rab-
bit anti-Ionized calcium binding adaptor molecule 1 (Iba1) antibody
(Wako; 1:1000) in T-PBS plus 5% BSA for 1 h RT. After rinsing in
T-PBS, cells were incubated with N-(7-nitrobenz-2-oxa-1,3-diazol-
4-yl) phallacidin (NBD-PhallAcidin, Molecular Probes; 100 U/ml, 1:30)
to selectively label F-actin, and Cy3 donkey-anti-rabbit (Jackson
Immunoresearch; 1:200) in PBS, 1 h at RT. Coverslips were then
mounted with DAKO ﬂuorescent mounting medium.2.4. Reverse transcription and real time PCR
Total RNA (1 μg) from each samplewas transcribed into cDNAusing
the RT-PCR Superscript III kit (Invitrogen, Eugene, OR, U.S.A.) according
to themanufacturer's instructions. Real-time PCRwas performed on the
reverse transcription (RT) products with SensiMix SYBR Kit (Bioline,
UK), or (for the arginase-1 mRNA expression) with SensiMix II probe
Kit (Bioline, UK), following the manufacturer's instructions, using an
ABI Prism 7000 Sequence Detection System (Applied Biosystems
Inc, Foster City, CA, U.S.A.). Primer sequences (from MWG Operon,
Ebersberg, Germany) and accession numbers are listed in Table 1.
Annealing temperaturewas 60 °C for all the primer pairs listed. All sam-
ples were run in triplicate, and each well of PCR contained 20 μl as a
ﬁnal volume of reaction, including 2 μl of cDNA corresponding to
20 ng of total RNA, 750nM of each primer and 10 μl of PCR master
mix. Thermal cycling conditions were as follow: 1 cycle at 95 °C for
10 min; 40 cycles 95 °C for 15 s and 60 °C for 1 min. Expression levels
of genes of interest were compared between control unstimulated cul-
tures and H-BCAA, LPS or LPS/H-BCAA cultures using the Relative Quan-
tiﬁcation (ΔΔCt) Study of Applied Biosystems 7000 System SDS
Software. Hypoxanthine guanine phosphoribosyl transferase (HPRT)
was used as internal control gene and ampliﬁcation speciﬁcity was
checked using a melting curve, following the manufacturer's instruc-
tions. The reference group used is indicated in the Results section, for
each study.
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Migration of microglial cells was assessed using transwell migra-
tion chambers (8 μm-pore polycarbonate ﬁlters in 24-wells Costar,
St. Louis, MO), according to previously published procedures [15]. In
brief, the bottom wells were ﬁlled with medium alone or medium
containing 10 μM ADP. Microglial cells were plated into the top
wells (6×104 cells/well) in control medium or H-BCAA, without
serum, and incubated for 4 hours at 37 °C. Migrated cells were counted
on the lower surface of the ﬁlters after ﬁxation in 100% methanol for
3 min and hematoxylin and eosin (H&E) staining. Cells on the top side
of the ﬁlter were wiped off using a cotton bud. Filters were then re-
moved from the inserts and mounted on glass slides with the stained
cells on the upper side, and the cells were counted under a light micro-
scope (16 ﬁelds were examined for each condition).
2.6. Phagocytosis assay
Phagocytosis was evaluated by using 6 μm diameter ﬂuorescent
beads (Polysciences,Milan, Italy). The beads, purchased as aqueous sus-
pension of 2.5% solid-latex (corresponding to 2×108 beads/ml), were
opsonized for 30 min at 37 °C in Kreb's Ringer PBS containing 50% of
fetal calf serum and then added to cells at the ratio of 105 opsonized
beads/7×104 cells. Cells were incubated with beads at 37 °C in 5% CO2
for 45 min. In some experiments, to induce the phagocytic activity of
microglia, cells were pre-incubated with 100 μM UDP for 30 min at
37 °C, before performing the phagocytosis assay. After incubation,
cells were washed twice with PBS for 2 min to remove excess beads.
Cells were ﬁxed with 4% PFA for 15 min at room temperature, washed
for 10 min with PBS and subsequently processed for Iba-1 staining.
The latex beads were visualized using ﬂuorescence microscopy. The
percentage of Iba-1 positive phagocytosing cells on total cell number
in each ﬁeld was counted. Ten ﬁelds for each experimental condition,
run in triplicate, were counted in at least 3 independent experiments.
2.7. Cytokines, insulin growth factor-1, F2-isoprostane and
NO determination
Speciﬁc ELISAs for tumor necrosis factor-α (TNF-α, interleukin 1β
(IL-1β), interleukin 10 (IL-10) (Endogen Inc., Woburn, U.S.A.) and
insulin-like growth factor-1 (IGF-1, Boster Biological Technology,
Rome, Italy) were used to assay microglial culture media, following
the manufacturer's instructions. The ranges of determination were:
31–2500 pg/ml for TNF-α, 25–25,000 pg/ml for IL-1β; 16–500 pg/ml
for IL-10; 31–2000 pg/ml for IGF-1.
Levels of 15-F2t-isoprostane (15-F2t-IsoP) were measured by a
sensitive enzyme immunoassay (detection limit: 2 pg/ml; Cayman
Chemical, Ann Arbor, MI, U.S.A.), according to the manufacturer in-
structions. All measurements were done at least in duplicate.
The production of nitric oxide (NO) was determined by measuring
the content of nitrite, one of the end products of NO oxidation in
the media, as previously described [16]. A standard nitrite curve
(0.25–50 μM) was generated using a 10 mM solution of NaNO2. All
chemical for the NO assay were from Sigma (EU).
2.8. Arginase assay
The colorimetric assay for the measurement of arginase activity
was performed in accordance to previously described protocols [17].
Brieﬂy, cells were washed twice with PBS 0.5% BSA, then lysated at
37 °C for 25 min in 60 μl/well of lysis buffer (0.1% Triton X-100 in
water, freshly completed with 10 mM leupeptin and 5 mM aprotinin)
and subjected to 3 freeze-thaw cycles. Standard urea solutions
(20 mM to 0.156 mM) were prepared by serial dilutions of 0.1 M
urea in lysis buffer. Blank samples, consisting of lysis buffer without
urea, were included. Following centrifugation at 240 rcf for 5 min,50 μl of lysates, standard solutions and blanks were transferred into
1.5 ml microfuge tubes (remaining lysate aliquots are stored at
−20 °C until protein quantiﬁcation). 50 μl of 25 mM Tris–HCl and
10 μl of 50 mMMnCl2 were added to all samples (lysates, standard so-
lutions and blanks) and themixture heated at 56 °C for 10 min. 100 μl
of 500 mM L-arginine were added to all samples and incubated at
37 °C for 30 min. L-arginine hydrolysis was stopped by adding 800 μl
of acid solution [96% H2SO4: 85% H3PO4: H2O (1:3:7)] to all samples.
40 μl of 9% α-isonitrosopropiophenone (in ethanol) was added to all
samples and incubated for 45 min at 95 °C. At the end of incubation,
200 μl of each sample were transferred into 96-well ﬂat-bottom
plate and the absorbance read at 540 nm (reference ﬁlter 670 nm),
using a microplate spectrophotometer reader. Arginase activity is
given as μmoles/ml.
2.9. Determination of mitochondrial membrane potential
To measure mitochondrial membrane potential the potentiometric
dye tetramethylrhodamine ethyl ester perchlorate (TMRE) was used
at a ﬁnal concentration of 30 nM (from 1 mM stock solution in
DMSO). Cells were kept for 30 min in the presence of TMRE before re-
cording, in order to reach saturation of the dye, and maintained
throughout the entire experiment to avoid the decay of the signal. An
oil immersion objective (Olympus: 40×, 1.35 NA) mounted on an
inverted microscope (Axiovert 135, Zeiss; Germany) was utilized for
ﬂuorescence video imaging. The excitationwavelength 535 nmwas ap-
plied bymeans of amonochromator (Till Photonics, Polychrome II; Ger-
many) and the emission light at 590 was collected by a CCD, cooled
digital camera (PCO, Sensicam; Germany) and recorded. The Imaging
Workbench 6.0 software package (Indec BioSystems; CA, USA) was
used for recording and off-line analysis of the data. The software
allowed the measurement of the emission value in regions of interest
or along line proﬁles, where peaks of amplitude corresponded to single
mitochondria. The average amplitudes of the ﬂuorescence intensity
were calculated (from aminimum of 3 experiments for each condition)
and shown in bar graphs as average±SEM, with n=number of
observations.
2.10. Western blot analysis
Cell lysates were prepared as previously described [16]. Brieﬂy,
microglial cells were lysed in ice cold RIPA buffer (50 mM Tris–HCl
supplemented with 1% NP40, 0.1% SDS, 0.1% Sodium desoxycholate,
1X Protease Inhibitor Cocktail, Sigma, 10 mM NaF, 100 μM Na3VO4)
and insoluble material removed by centrifugation (10,000 ×g at 4 °C,
10 min). Protein concentration was measured and equal amounts
(50 μg) separated by 4–12% SDS-PAGE (Invitrogen) and transferred
to nitrocellulose membranes. Membranes were blocked with 7%
non-fat milk and incubated with rabbit anti-phospho-p70S6 Kinase
(Cell Signaling; 1:1000), recognizing p70 S6 Kinase when phosphory-
lated at threonine 389, and rabbit anti-p70 S6 Kinase (Cell Signaling;
1:1000) antibodies, overnight at 4 °C. The housekeeping gene actin
was recognized by mouse anti-actin antibody (Sigma; 1:5000, 1 h at
RT). Horseradish peroxidase conjugated anti-rabbit and anti-mouse
IgG (Thermo, Pierce 1:10,000, 1 h at RT) and enhanced chemilumines-
cence ECL reagents (Thermo, Pierce) were used as detection system.
Band detection and image capture were performed by ChemiDoc
XRS Densitometer (Bio-Rad) and Image LabTM 4.0 software; band
quantiﬁcation was performed by Image LabTM 4.0 software; intensi-
ties of bands corresponding to P-p70S6K and Tot-p70S6K were nor-
malized over the corresponding actin band.
2.11. MTT crystal violet and protein assays
The ability of cells to reduce 3-(4,5-dimethyl thiazol-2-y1)-2,5-
diphenyl tetrazolium bromide (MTT) was assessed as index of cellular
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[17]. MTT was added at a ﬁnal concentration of 0.25 mg/ml during the
ﬁnal 4 h of incubation. The medium was then removed, and 100 μl
DMSO added to each well to dissolve the dark blue crystals. The platesB
0
10
20
30
40
50
15
-F
2t
-
Is
oP
 (p
g/m
l)
Ctr H-BCAA
*
C
A
m
R
N
A
 le
ve
ls
(fo
lds
 in
cr
ea
se
 ov
er
 C
tr)
 
IL1 iNOS TNF
M1
*
*
*
0.0
0.5
1.0
1.5
2.0
2.5 1 mM 
Iba-1 actin
Ctr
H-BCAA
Fig. 1. Effects of high levels of BCAAs on microglia morphology, gene expression, free radica
that had been cultivated in normal (Ctr) or high BCAAmedium (H-BCAA), were maintained f
the indicated analysis. A. Photomicrographs showing the morphology of microglial cells gr
immunostained for the microglial marker Iba-1 (red) followed by phallacidin staining (gre
time PCR of M1 and M2 genes in H-BCAA (1 and 10 mM) microglial cultures. Data are giv
as 1 (dotted line). * pb0.05 versus Ctr cultures. Data are mean±SEM of 3 to 5 independen
idation product 15-F2t-IsoP, as index of free radical generation, in the culture media of Ctr an
experiments, run in duplicate. Right panel: Accumulation (24 h) of IGF-1 in the culture med
independent experiments, run in duplicate.were then read on a microplate reader, using a test wavelength of
570 nm and a reference wavelength of 630 nm. The cell number in
each condition was estimated by crystal violet (CV) dye [18]. Protein
concentration was measured by BCA protein assay (Thermo, Pierce).IG
F-
1 
(p
g/m
l) 
*
0
200
400
600
800
Ctr H-BCAA
IL10 Arg-1 MRC-1
M2
*
10 mM 
merge
l generation and IGF-1 production. Microglial cells, harvested from mixed glial cultures
or a further 24 h in the two culture conditions (Ctr and H-BCAA) and then processed for
own in control (Ctr) or in 10 mM BCAA supplemented medium (H-BCAA). Cells were
en) to selectively label ﬁlamentous actin. Scale bar=25 μm. B. mRNA analysis by real
en as fold change over the expression of the corresponding gene in Ctr cultures taken
t experiments, run in duplicates. C. Left panel: accumulation (24 h) of the lipid perox-
d H-BCAA cultures. * pb0.01 versus Ctr cultures. Data are mean±SEM of 6 independent
ia of Ctr and H-BCAA cultures. * pb0.01 versus Ctr cultures. Data are mean±SEM of 3
Fig. 2. Effects of high levels of BCAAs on mitochondrial function and morphology. Cells
were harvested and maintained as for Fig. 1. A. Mitochondrial membrane potential
(mMP) in the two culture conditions was measured by using the potentiometric dye
TMRE in single cell video-imaging experiments. Data are mean±SEM and are
expressed as arbitrary units (AU). B. Example of mitochondrial shape and density in
microglial from Ctr and H-BCAA cultures. C. Mitochondrial activity was also measured
by MTT reduction; the values of MTT reduction were normalized for the cell number,
evaluated by CV assay. Data are given as mean±SEM of MTT/CV, expressed as % of con-
trol; n=5 independent experiments, run at least in duplicate.
Fig. 4. Effects of high levels of BCAAs onmicroglial phagocytosis of opsonised ﬂuorescent
beads. Microglial cells from Ctr and H-BCAA cultures were incubated with 6 μm diameter
beads at 37 °C for 45 min. As positive control, phagocytic activity was induced by
pre-incubating microglial cells with 100 μM UDP for 30 min at 37 °C before adding the
beads. At the end of incubation, cells were washed twice, ﬁxed and processed for Iba-1
staining. Phagocytosis was examined by ﬂuorescence microscopy (A). Arrow heads in
panel A indicate engulfed beads (scale bar=25 μm). In panel B, a confocal microscopy
image of particles engulﬁng a cell (arrow head) is given: scale bar=10 μm. The percent-
age of Iba-1 positive cells engulﬁng ﬂuorescent beads on total cell number in eachmicro-
scopic ﬁeld (10 ﬁelds for each condition) was counted and given as mean±SEM (n=3
independent experiments, run in triplicates). *pb0.05 versus control.
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Data are expressed as means+SEM of (n) independent experi-
ments (run in duplicate). Statistical signiﬁcance was evaluated using
Student's t test or one-way ANOVA followed by Bonferroni's correc-
tion for multiple comparisons. Numbers of independent experiments
are indicated in the ﬁgure legends; pb0.05 was accepted as statistical
signiﬁcance. Analyses were performed using StataTm 8.1 software
(Stata Corporation, College Station, TX).
4. Results
4.1. High levels of BCAAs inﬂuence microglial gene expression proﬁle and
free radical production
Microglial cells were harvested from mixed glial cultures that had
been cultivated in control (Ctr) or high BCAA medium (H-BCAA) forFig. 3. Effects of high levels of BCAAs on microglial motility and migration. Motility of
microglial cells was assessed using transwell migration chambers. Microglial cells from
Ctr and H-BCAA cultures were plated into the topwells (6×104 cells/well) in control me-
diumorH-BCAA,without serum; bottomwellswereﬁlledwithmedium alone ormedium
containing 10 μM ADP. Cells were incubated for 4 h at 37 °C and after ﬁxation and H&E
staining, 16 ﬁelds were examined for each condition. Data are given as % of cells migrated
in untreated control cultures, taken as 100%; n=3 independent experiments.
Fig. 5. Effects of high levels of BCAAs on LPS-induced M1 and M2 gene expression. A.
mRNA analysis by real time PCR of M1 andM2 genes induced by LPS in Ctr microglial cul-
tures. Cells were stimulatedwith 10 ng/ml LPS for 6 hrs, harvested and cDNA analysed by
real time PCR. Data are given as folds increase over the expression of the corresponding
gene in unstimulated Ctr cultures. Data aremean±SEM of 3–5 independent experiments,
run in duplicate. All values are signiﬁcantly different from control. B. mRNA analysis by
real time PCR of M1 and M2 genes induced by LPS in H-BCAA cultures. Cells were treated
and analysed as described for panel A. Data are given as % of increase or decrease over the
corresponding gene in LPS-control medium (Ctr) cultures, with positive values indicating
an increase in the expression of the gene in H-BCAA cultures and negative values an inhi-
bition. Data are mean±SEM of 3–5 independent experiments, run in duplicate. *pb0.05
and **b0.001 versus LPS-stimulated Ctr cultures.
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24 h in the two culture conditions (Ctr and H-BCAA) and then
processed for the indicated analyses. The concentrations of BCAAs (1
and 10 mM), were selected on the basis of previously reported in
vitro studies [9,19] to mimic the abnormal BCAA plasma levels
reported in MSUD patients or in athletes after acute administration
of BCAAs as dietary integrators to improve physical performance and
fatigue resistance [2]. At 10 mM concentration, BCAAs did not affect
microglial viability (see material and method section) or total protein
synthesis (40±6 and 51±8 μg/105 cells, for Ctr and H-BCAA cultures,
respectively; n=6). Cell morphology (Fig. 1A), was modestly affected
by H-BCAAs as assessed by staining microglial cultures with the cyto-
solic Ca2+ binding protein Iba-1, although staining for F-actin re-
vealed some differences suggestive of cytoskeleton reorganization.
Doubly stained cells (Fig. 1A, right panels), showed a localisation of
both Iba1 and F-actin at the rim of the cell membranes, consistent
with the ability of Iba-1 to bind actin and with its involvement in
RacGTPase-dependent membrane rufﬂing and phagocytosis [20,21].
The analysis of the expression of a panel of genes associated either to
M1 (IL-1β, iNOS, TNF-α), or M2 (IL-10; arginase-1, Arg-1; mannoseUntreated LPS-treated
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detailed under Materials and methods section. Arginase activity is also shown in panel B. *pb
nitrite and TNF-α in cells maintained in culture medium supplemented with 1 mM BCAA a
induced by LPS in Ctr cultures. *pb0.05 versus Ctr cultures, ** pb0.05 versus Ctr cultures an
duplicate.receptor, MRC-1), microglial phenotype (Fig. 1B), revealed lower levels
of transcripts encoding for all three M1 genes in microglial cultures ex-
posed to 10 mM BCAAs as compared to control cultures. Of the typical
M2 genes examined, MRC-1 expression was signiﬁcantly increased in
H-BCAA cultures while the expression of IL-10 and Arg-1 remained un-
affected. mRNA levels of all six genes were not signiﬁcantly altered in
cultures exposed to 1 mMBCAAs. Thus, we focused most of our further
analyses on cultures exposed to 10 mM BCAAs.
Next, we analysed the accumulation in the culture media of
15-F2t-IsoP, a lipid peroxidation product and a well established oxida-
tive stress biomarker [22], and of IGF-1, an importantmicroglial product
with neuroprotective and anti-inﬂammatory activities. We found a
moderate, albeit signiﬁcant, increase in the 15-F2t-IsoP levels (Fig. 1C,
left panel), and a strong reduction in IGF-1 production (Fig. 1C, right
panel) in H-BCAA cultures as compared to control cultures.
These results suggest that BCAAs, either indirectly (through their
potential actions on astrocytes during the 6 days in the mixed glial cul-
tures), or directly (during the 24 h incubation of puriﬁedmicroglial cul-
tures), inﬂuence the functional properties of microglial cells and induce
an incomplete polarisation toward the M2 phenotype.0
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potential and morphology
Since BCAAs have been shown to impair mitochondrial functions
possibly through the generation of free radicals at mitochondrial
level [23], we measured the mitochondrial membrane potential
(mMP) as index of electron transport chain integrity. Changes in
mMP (Δψm) were measured by using the potentiometric dye TMRE
in single cell video-imaging experiments. The intensities of the
TMRE ﬂuorescence signal were comparable in the two culture condi-
tions (Ctr and H-BCAA; Fig. 2A), thus suggesting that BCAAs do not in-
duce mitochondrial membrane depolarization. The two cell culture
types also showed similar MTT reducing activities (Fig. 2B); MTT is
taken up by living cells and it is reduced by mitochondrial NADH-
dependent dehydrogenases (mainly succinate dehydrogenase or
complex II of the respiratory chain), thus providing a measure of the
mitochondrial activity, generally used as an index of cell viability.
The absence of mitochondrial damage, suggested by the mMP and
MTT measurements, was consistent with the preserved rod-like
shape morphology of mitochondria in both Ctr and H-BCAA cultures,
as evidenced by visual inspection of TMRE loaded mitochondria
(Fig. 2C).
4.3. High levels of BCAAs do not affect microglial motility but
promote phagocytosis
We next analysed whether the altered gene expression induced by
BCAAs could inﬂuence important functions such as motility and phago-
cytosis.We performed a chemotaxis assay to evaluate the basal motility
of control and H-BCAAmicroglial cells aswell as their ability to respond
to a well deﬁned microglial chemoattractant such as ADP [15]. AsA
%
of
 L
PS
-C
tr 
Rapa 
LPS 
H-BCAA 
+ +
0
25
50
75
100
125 NO TNFα
* * 
* * 
C
-
-
+ + +
+ +
Tot-p70 S6K 
P-p70 S6K 
Actin
Actin
Ctr H-B
CA
A
H-B
CA
A+
Ra
pa
Ctr
+R
a
Fig. 7. Effects of rapamycin and high levels of BCAAs on LPS-induced NO, TNFα and arginase a
H-BCAA cultures, with and without 5 nM rapamycin. Microglial proteins were analyzed by we
dependent experiments, run in duplicate. B. Ratios of phosphorylated p70 S6K (P-p70) and to
expressed as % of control and are mean±SEM of n=3 independent experiments, run in dupl
with LPS (10 ng/ml) in the presence of 5 nM rapamycin. Accumulation of nitrite and TNF-αwe
tures. *pb0.05 versus LPS-stimulated Ctr cultures. D. Arginase activity wasmeasured inmicrogl
in Ctr cultures. *pb0.05 versus LPS-stimulated Ctr cultures. Data in panels C and D are mean±shown in Fig. 3, there was no difference between Ctr and H-BCAA cul-
tures, in both basal and ADP-induced microglial motility.
To examine phagocytosis, we assessed the engulfment of opsonised
ﬂuorescent latex beads by Iba-1 positive cells, a speciﬁc marker for
microglia (Fig. 4). We observed a higher percentage of particle-
engulﬁng cells in H-BCAA cultures than in Ctr cultures. Phagocytosis
in H-BCAAmicroglia was comparable to that evoked by 100 μMuridine
5 -diphosphate (UDP), a known inducer ofmicroglial phagocytosis [24].
4.4. High levels of BCAAs alter microglial immunological proﬁle in
response to LPS activation
Finally, we investigated the expression proﬁle of M1 and M2 genes
in response to a prototypical inﬂammatory stimulus such as LPS. As
expected, in control cultures, LPS decreased MRC-1 gene expression
and increased the levels of the transcripts for the remaining genes
(Fig. 5A). When the LPS-induced mRNA levels in H-BCAA cultures
were compared to those induced in control cultures, we observed a re-
duced ability of H-BCAA microglia to express IL-1β and iNOS (Fig. 5B).
The decreased mRNA levels were reﬂected in decreased amounts of
IL-1β and NO (measured as nitrites) accumulated in culture media
(Fig. 6A). A signiﬁcant decrease in IL-1β and nitrite levels was also ob-
served in cultures maintained in 1 mM BCAA-supplemented medium
and challengedwith LPS (Fig. 6C). In the case of TNF-α, therewas nodif-
ference in mRNA levels between Ctr and H-BCAAmicroglial cells but at
protein levels TNF-αwas substantially reduced in H-BCAA cultures, in-
dicating a post-transcriptional regulation of this geneby BCAAs (Figs. 5B
and 6A, bottom panel).
Among theM2 genes, IL-10 andMRC-1mRNA levels were increased
(Fig. 5B). The increased expression of IL-10 inH-BCAA cultureswas con-
ﬁrmed at protein level (Fig. 6B). However, when looking at Arg-1, a%
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phages, both mRNA expression and enzymatic activity were substan-
tially lower in H-BCAA than in Ctr microglial cells (Figs. 5B and 6B).
4.5. Rapamycin does not prevent the altered response to LPS of microglial
cells exposed to high levels of BCAAs
It has been reported that many of the activities of BCAAs are me-
diated by signalling involving the mammalian target of rapamycin
(mTOR). We ﬁrst evaluated the phosphorylation of p70 S6 Kinase, a
Ser/Thr kinase downstream to mTOR activation (Fig. 7A–B). We
used an antibody recognizing p70 S6 kinase upon phosphorylation
of Thr389, which closely correlates with in vivo p70 S6 kinase activity
and is blocked by rapamycin. The level of phosphorylated p70 6S Ki-
nase was increased in H-BCAA cultures as compared to Ctr cultures.
Such phosphorylation was abrogated in the presence of rapamycin,
used at 5 nM concentration according to previous studies on primary
microglial cultures [25,26]. In H-BCAA cultures, rapamycin did not
affect cell viability or number (MTT assay, 107±14 and CV assay,
103±3% of control for control). In control cultures, the presence of
rapamycin did not affect cell viability (91±8% of control cultures,
n=5) but slightly decreased the cell number (92±1% of control,
pb0.05, n=5).
The presence of 5 nM rapamycin did not inﬂuence the levels of ni-
trite or TNF-α induced by LPS and it did not reverse the inhibitory ef-
fects exerted by high levels of BCAAs (Fig. 7C). We also tested the
effect of rapamycin on LPS-induced arginase activity (Fig. 7D). In con-
trol cultures, rapamycin signiﬁcantly reduced arginase activity,
suggesting that mTOR signalling is involved in Arg-1 expression fol-
lowing LPS-activation, as described for other M2 genes in monocytes
and dendritic cells [27]. Rapamycin had no effect on arginase activity
in H-BCAA cultures exposed to LPS, nor on basal levels of nitrite,
TNF-α and arginase (not shown). Altogether, these data indicate
that inhibition of mTOR by rapamycin does not counteract the effects
of BCAAs, at least as far as NO and TNF-α production and arginase ac-
tivity is concerned.
5. Discussion
BCAAs are important nutrients and signalling molecules, acquired
with diet, with critical roles for normal growth and functions of the
whole organism. During exercise or starvation, protein breakdown in-
creases BCAA availability and catabolism, which occurs largely in mi-
tochondria of brain, muscles and adipose tissue [3]. The ﬁnal products
of BCAA catabolism then enter the tri-carboxylic acid cycle to produce
reduced nicotinamide adenine dinucleotide for mitochondrial respi-
ration. In addition, within the brain, BCAAs participate either directly
or indirectly to the synthesis of neurotransmitters and in maintaining
the nitrogen balance of the glutamate–glutamine cycle between as-
trocytes and neurons [28,29]. BCAA homeostasis is therefore essential
to normal brain physiology.
In the present study, we show that the protracted exposure to
high levels of BCAAs alters the immune properties of microglia, the
main immunocompetent cells of the brain parenchyma, and suggest
a novel action for BCAAs as modulators of central immune response.
Microglial cells cultured in high BCAA-containing medium under
unstimulated conditions exhibit a lower expression of the M1 genes
IL-1β, TNF-α and iNOS and a concomitant higher expression of the
M2 gene MRC-1. These features would suggest a less reactive pheno-
type. However, these cells are also characterized by an increased pro-
duction of reactive oxygen species, as indicated by the higher levels of
the lipid peroxidation product 15-F2t-IsoP, and by a lower production
of the neuroprotective factor IGF-1, suggesting an unbalance in favour
of neurotoxic activities.
H-BCAAmicroglial cultures showan increased capacity to phagocyte
opsonised ﬂuorescent latex beads, in agreement with the enhancedlevels of transcripts for MRC-1 (or CD206), one of the several receptors
mediating phagocytosis in microglial and perivascular macrophages
[30]. Phagocytosis is an important physiological function of microglia,
as clearance of dead cells or dangerous debris is crucial to the mainte-
nance of brain functions and sustained phagocytic activity is typical
for M2 macrophages and microglia [31,32].
Other microglial functions, such as basal motility and migration in
response to a well deﬁned microglial chemoattractant such as ADP,
were comparable in control and H-BCAA cultures.
Furthermore, although mitochondrial respiratory chain activity
was decreased in rat cerebral cortex slices acutely exposed to mM
concentrations of BCAAs [23], H-BCAA microglial cultures presented
unaltered mitochondrial functions, as indicated by morphology and
measurements of mMP and MTT reduction activity. In line with our
observations, 10–50 mM BCAAs did not induce mitochondrial mem-
brane depolarisation in glial and neuronal cell lines [19]. Mitochon-
drial respiratory chain dysfunctions are known to hamper the
process of microglial alternative activation [33], but our observations
suggest that mitochondrial impairment is not the mechanism by
which BCAAs prevent the acquisition of a full M2 phenotype.
A further result of our study is that H-BCAA microglial cells re-
spond differently to Toll receptor-4 (TLR-4)-mediated activation as
compared to controlmicroglial cultures. In H-BCAA cultures, the levels
of NO, IL-1β and TNF-α induced by LPS were signiﬁcantly decreased,
suggesting a milder inﬂammatory reaction. Other M2-associated
genes, such as IL-10 and MRC-1, were increased, suggesting that, in
the presence of high BCAA levels, the pattern of activation is skewed
towards the M2 phenotype. Nonetheless, both Arg-1 mRNA expres-
sion and arginase activity were substantially lower than in Ctr cul-
tures, further supporting the failure of H-BCAA cultures in acquiring
a full M2 phenotype. Arginase-1 competes with iNOS for the common
substrate L-arginine and transforms it into urea and ornithine, the
precursor of a family of small molecules termed the polyamines.
Spermidine and spermine, two of the most important polyamines,
have neuroprotective functions and are essential for neurite out-
growth, neuronal survival and regeneration [34,35]. As for the de-
creased synthesis of IGF-1 in unstimulated cultures, the low levels of
expression/activity of Arg-1 in activated H-BCAA microglia could re-
sult in a substantial lack of neurotrophic activities.
Among the molecular regulators of innate immune response is
mTOR pathway. In LPS-stimulated human monocytes and dendritic
cells, mTOR activity has been suggested to regulate M1/M2 gene ex-
pression by favouring M2 phenotype [27]. However, in LPS-stimulated
PBMC [36] and LPS-activated microglial cells [25, and the present
study], mTOR seems to fulﬁl this role only as far as M2 genes is
concerned since iNOS/NO and TNF-α levels were not affected by
rapamycin whereas arginase activity was substantially inhibited.
Many of the activities of BCAAs are mediated by mTOR, including the
recently described hyperexcitability of cortical neurons [10]. Under
our experimental conditions rapamycin did not prevent the BCAA-
dependent decrease in NO and TNF-α production induced by LPS. Fur-
thermore, both rapamycin and BCAAs lowered arginase activity and
the results were not additive. These observations suggest that mTOR
is not necessary for BCAA activity in LPS-activated microglial cells.
Altogether, our observations suggest that the exposure to high levels
of BCAAs affects themicroglial immune properties in a peculiarmanner,
promoting the acquisition of an intermediate phenotype that is less in-
ﬂammatory than the M1 and less protective than the M2. We hypothe-
size that this unique functional phenotype could result in a low-grade
inﬂammatory state and a less efﬁcientmicroglial response to local dam-
age, two features that might increase the susceptibility to neurodegen-
erative processes. In this light, loss of microglial surveillance function
has been recently described in a mouse model of amyotrophic lateral
sclerosis, during the clinical phase of disease [37]. These authors suggest
that the altered functions of microglia may be instrumental for
neurodegeneration: if on one side, an overactive reaction to tissue
658 R. De Simone et al. / Biochimica et Biophysica Acta 1832 (2013) 650–659damage may be harmful to neurons and axons, on the other a rapid re-
sponse is required for an efﬁcient clearance of debris and neurotoxic
molecules, and the resolution of the ongoing focal neurodegeneration.
Although based on in vitro evidence, our results add on to an in-
creasing literature casting doubts on the safety of large consumption
of BCAAs as dietary integrators. BCAA dietary supplementation is in-
dicated in pathologic conditions in which plasma BCAA concentration
is signiﬁcantly reduced – e.g. hepatic cirrhosis, traumatic brain injury,
obesity and geriatric patients [38] –with the intention of normalizing
amino acid proﬁles and nutritional status. The mechanisms by which
BCAAs exert beneﬁcial effects in these pathological states are not fully
elucidated but they vary, according to the speciﬁc tissue target (adi-
pose tissue, muscles, brain). In addition, BCAA supplementation is
commonly used to improve physical and mental performance in ath-
letes [2,4,39]. Depletion of BCAAs in muscle and plasma induced by
exercise can produce a negative impact on muscle energy economy.
Since BCAAs enter the brain through a transporter that they share
with a number of large neutral amino acids including tryptophan, a
drop in BCAA levels could indirectly increase tryptophan uptake
into brain and stimulate neuronal synthesis and release of serotonin.
On this basis, the assumption that high BCAA intake could prevent
muscle and “central” fatigue has been put forward although no con-
clusive results on the beneﬁcial effects of BCAA supplementation in
athletes are yet available [2]. In contrast, there is an increasing con-
cern on the abuse of BCAA-containing dietary integrators and ener-
getic drinks, particularly in adolescents and young adults [40–42]. In
addition to a decrease in serotonin synthesis and release, a high in-
take of BCAAs could result in increased levels of glutamate, formed
from BCAA transamination. Glutamate is the main excitatory neuro-
transmitter and the substrate for the synthesis of the major inhibitory
neurotransmitter γ-aminobutyric acid (GABA). It has been proposed
that BCAAs and their branched-chain α-keto-acids participate in
maintaining the nitrogen balance in the glutamate-glutamine cycle
between astrocytes and neurons, serving as “shuttle” molecules for
amino groups [28,29,43]. An excess of BCAAs could upset the balance
and increase the likelihood of excitotoxicity. In this context, it is
tempting to speculate that a less efﬁcient microglial surveillance
could impede damage resolution and allow a condition of detrimental
low-grade inﬂammation.
Of note, on the basis of epidemiological and experimental studies,
the excessive use of dietary integrators including BCAAs has been
proposed as one of the factors that could explain the increased risk
of amyotrophic lateral sclerosis in professional soccer players as com-
pared to the general population [44–47].6. Conclusions
This study shows that in the presence of high levels of BCAAs
microglial cells exhibit a peculiar phenotype characterized by a par-
tial skewing toward the M2 state that could results in a less efﬁcient
microglial response to local damage and the establishment of a
low-grade inﬂammatory state. In addition to the described BCAA-
induced hyperexcitability and excitotoxiticy, the altered immune pro-
ﬁle of microglia may represent a further mechanism by which impor-
tant nutrients and potent signalling molecules such as BCAAs might
turn into toxicants and increase the likelihood of neurodegenerative
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